{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:49:40Z","timestamp":1793638180348,"version":"4.5.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00345-019-03016-x","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T06:01:56Z","timestamp":1574056916000},"page":"2261-2268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Urinary biomarkers profiles in patients with neurogenic detrusor overactivity according to their neurological condition"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4374-5665","authenticated-orcid":false,"given":"Claire","family":"Richard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Bendavid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Hascoet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Alimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zine-eddine","family":"Khene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Kerdraon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Voiry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charl\u00e8ne","family":"Brochard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bouguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Siproudhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Manunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Gam\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"issue":"3","key":"3016_CR1","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/nau.23397","volume":"37","author":"JB Gajewski","year":"2018","unstructured":"Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agr\u00f2 EF et al (2018) An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn 37(3):1152\u20131161","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 3","key":"3016_CR2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/nau.22636","volume":"33","author":"F Haab","year":"2014","unstructured":"Haab F (2014) Chapter 1: the conditions of neurogenic detrusor overactivity and overactive bladder. Neurourol Urodyn 33(Suppl 3):S2\u2013S5","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"3016_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1166-7087(07)92379-9","volume":"17","author":"A Ruffion","year":"2007","unstructured":"Ruffion A, de S\u00e8ze M, Denys P, Perrouin-Verbe B, Chartier-Kastler E, Groupe d\u2019Etudes de Neuro-Urologie de Langue Fran\u00e7aise (2007) Groupe d\u2019Etudes de Neuro-Urologie de Langue Fran\u00e7aise (GENULF) guidelines for the management of spinal cord injury and spina bifida patients. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol 17(3):631\u2013633","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"issue":"10","key":"3016_CR4","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1074\/mcp.R800001-MCP200","volume":"7","author":"S Decramer","year":"2008","unstructured":"Decramer S, Gonzalez de Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands J-L et al (2008) Urine in clinical proteomics. Mol Cell Proteom 7(10):1850\u20131862","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"3016_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.purol.2014.11.004","volume":"25","author":"B Peyronnet","year":"2015","unstructured":"Peyronnet B, Bendavid C, Manunta A, Damphousse M, Cheensse C, Brochard C et al (2015) The role of urinary markers in the assessment and follow-up of lower urinary tract disorders: a literature review. Progres En Urol J Assoc Francaise Urol Soc Francaise Urol 25(4):188\u2013199","journal-title":"Progres En Urol J Assoc Francaise Urol Soc Francaise Urol"},{"issue":"7","key":"3016_CR6","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/nau.23207","volume":"36","author":"T Top","year":"2017","unstructured":"Top T, Sekerci CA, Isbilen-Basok B, Tanidir Y, Tinay I, Isman FK et al (2017) The effect of intradetrusor botulinum neurotoxin type A on urinary NGF, TGF BETA-1, TIMP-2 levels in children with neurogenic detrusor overactivity due to myelodysplasia. Neurourol Urodyn 36(7):1896\u20131902","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"3016_CR7","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","volume":"56","author":"H-T Liu","year":"2009","unstructured":"Liu H-T, Chancellor MB, Kuo H-C (2009) Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 56(4):700\u2013706","journal-title":"Eur Urol"},{"issue":"5","key":"3016_CR8","doi-asserted-by":"crossref","first-page":"1267.e13","DOI":"10.1016\/j.urology.2010.06.012","volume":"76","author":"H Yamauchi","year":"2010","unstructured":"Yamauchi H, Akino H, Ito H, Aoki Y, Nomura T, Yokoyama O (2010) Urinary prostaglandin E2 was increased in patients with suprapontine brain diseases, and associated with overactive bladder syndrome. Urology 76(5):1267.e13\u20131267.e19","journal-title":"Urology"},{"issue":"3","key":"3016_CR9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.wco.0000073925.19076.f2","volume":"16","author":"T Owens","year":"2003","unstructured":"Owens T (2003) The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr Opin Neurol 16(3):259\u2013265","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"3016_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-6147(03)00028-2","volume":"24","author":"O Neuhaus","year":"2003","unstructured":"Neuhaus O, Archelos JJ, Hartung H-P (2003) Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection. Trends Pharmacol Sci 24(3):131\u2013138","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"3016_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-3083.2005.01649.x","volume":"62","author":"M Caggiula","year":"2005","unstructured":"Caggiula M, Batocchi AP, Frisullo G, Angelucci F, Patanella AK, Sancricca C et al (2005) Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis. Scand J Immunol 62(2):176\u2013182","journal-title":"Scand J Immunol"},{"issue":"Suppl 1","key":"3016_CR12","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10072-006-0537-7","volume":"27","author":"R Hohlfeld","year":"2006","unstructured":"Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2006) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol Sci 27(Suppl 1):S1\u2013S7","journal-title":"Neurol Sci"},{"issue":"12","key":"3016_CR13","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.3390\/ijms131013713","volume":"13","author":"A Kalinowska-Lyszczarz","year":"2012","unstructured":"Kalinowska-Lyszczarz A, Losy J (2012) The role of neurotrophins in multiple sclerosis\u2014pathological and clinical implications. Int J Mol Sci 13(12):13713\u201313725","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3016_CR14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.10446","volume":"53","author":"M Kerschensteiner","year":"2003","unstructured":"Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53(3):292\u2013304","journal-title":"Ann Neurol"},{"key":"3016_CR15","first-page":"44","volume":"3","author":"IV Bazhenov","year":"2019","unstructured":"Bazhenov IV, Filippova ES, Bazarnyi VV, Sazonov SV, Volkova LI, Zaitseva LN (2019) Sensitivity and specificity of urinary and serum neurotrophins in the diagnosis of neurogenic detrusor overactivity in multiple sclerosis. Urol Mosc Russ 1999 3:44\u201348","journal-title":"Urol Mosc Russ 1999"},{"issue":"1","key":"3016_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.08.025","volume":"191","author":"\u00c7A \u015eekerci","year":"2014","unstructured":"\u015eekerci \u00c7A, I\u015fbilen B, I\u015fman F, Akbal C, \u015eim\u015fek F, Tarcan T (2014) Urinary NGF, TGF-\u03b21, TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia. J Urol 191(1):199\u2013205","journal-title":"J Urol"},{"issue":"4","key":"3016_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.juro.2018.05.006","volume":"200","author":"B Peyronnet","year":"2018","unstructured":"Peyronnet B, Even A, Capon G, De Seze M, Hascoet J, Biardeau X et al (2018) Intradetrusor injections of botulinum toxin A in adults with spinal dysraphism. J Urol 200(4):875\u2013880","journal-title":"J Urol"},{"issue":"S4","key":"3016_CR18","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/nau.23725","volume":"37","author":"CH Fry","year":"2018","unstructured":"Fry CH, Kitney DG, Paniker J, Drake MJ, Kanai A, Andersson K-E (2018) Fibrosis and the bladder, implications for function ICI-RS 2017. Neurourol Urodyn 37(S4):S7\u2013S12","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"3016_CR19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1464-410X.2008.07606.x","volume":"102","author":"JA Hipp","year":"2008","unstructured":"Hipp JA, Hipp JD, Yoo JJ, Atala A, Andersson K-E (2008) Microarray analysis of bladder smooth muscle from patients with myelomeningocele. BJU Int 102(6):741\u2013746","journal-title":"BJU Int"},{"issue":"4 Pt 2","key":"3016_CR20","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/01.ju.0000176633.92150.4e","volume":"174","author":"SH Beqaj","year":"2005","unstructured":"Beqaj SH, Donovan JL, Liu DB, Harrington DA, Alpert SA, Cheng EY (2005) Role of basic fibroblast growth factor in the neuropathic bladder phenotype. J Urol 174(4 Pt 2):1699\u20131703","journal-title":"J Urol"},{"issue":"5","key":"3016_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<525::AID-NAU8>3.0.CO;2-F","volume":"17","author":"J Janzen","year":"1998","unstructured":"Janzen J, Vuong PN, Bersch U, Michel D, Zaech GA (1998) Bladder tissue biopsies in spinal cord injured patients: histopathologic aspects of 61 cases. Neurourol Urodyn 17(5):525\u2013530","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"3016_CR22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrurol.2015.301","volume":"13","author":"L Vignozzi","year":"2016","unstructured":"Vignozzi L, Gacci M, Maggi M (2016) Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol 13(2):108\u2013119","journal-title":"Nat Rev Urol"},{"issue":"9","key":"3016_CR23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2174\/1381612824666171213102836","volume":"24","author":"CV Oztekin","year":"2018","unstructured":"Oztekin CV, Kaya-Sezginer E, Yilmaz-Oral D, Gur S (2018) Male urogenital disorders and metabolic syndrome: possible links, characteristics and potential treatment strategies. Curr Pharm Des 24(9):1019\u20131033","journal-title":"Curr Pharm Des"},{"issue":"1","key":"3016_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/pcan.2015.43","volume":"19","author":"Q He","year":"2016","unstructured":"He Q, Wang Z, Liu G, Daneshgari F, MacLennan GT, Gupta S (2016) Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links. Prostate Cancer Prostatic Dis 19(1):7\u201313","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"3016_CR25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/nau.22558","volume":"33","author":"CH Fry","year":"2014","unstructured":"Fry CH, Sahai A, Vahabi B, Kanai AJ, Birder LA (2014) What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013. Neurourol Urodyn 33(5):602\u2013605","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"3016_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/nau.22882","volume":"36","author":"M Gamper","year":"2017","unstructured":"Gamper M, Moser R, Viereck V (2017) Have we been led astray by the NGF biomarker data?: accurate NGF Assay? Neurourol Urodyn 36(1):203\u2013204","journal-title":"Neurourol Urodyn"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-03016-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-03016-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-03016-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:17:49Z","timestamp":1605572269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-03016-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["3016"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-03016-x","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"13 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics board approval number: CER-1491_20141215.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}